The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Fibrinogen-Global Market Insights and Sales Trends 2025
Synopsis
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
The global Human Fibrinogen market size is expected to reach US$ 2207 million by 2029, growing at a CAGR of 15.5% from 2023 to 2029. The market is mainly driven by the significant applications of Human Fibrinogen in various end use industries. The expanding demands from the Congenital Fibrinogen Deficiency and Surgical Procedures, are propelling Human Fibrinogen market. Human Fibrinogen Concentrate, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Animal Fibrinogen Concentrate segment is estimated at % CAGR for the next seven-year period.
Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Fibrinogen, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Fibrinogen market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Fibrinogen market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Fibrinogen sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Fibrinogen covered in this report include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical and Octapharma, etc.
The global Human Fibrinogen market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma
Global Human Fibrinogen market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Fibrinogen market, Segment by Type:
Human Fibrinogen Concentrate
Animal Fibrinogen Concentrate
Global Human Fibrinogen market, by Application
Congenital Fibrinogen Deficiency
Surgical Procedures
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Fibrinogen manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Fibrinogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
The global Human Fibrinogen market size is expected to reach US$ 2207 million by 2029, growing at a CAGR of 15.5% from 2023 to 2029. The market is mainly driven by the significant applications of Human Fibrinogen in various end use industries. The expanding demands from the Congenital Fibrinogen Deficiency and Surgical Procedures, are propelling Human Fibrinogen market. Human Fibrinogen Concentrate, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Animal Fibrinogen Concentrate segment is estimated at % CAGR for the next seven-year period.
Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Fibrinogen, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Fibrinogen market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Fibrinogen market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Fibrinogen sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Fibrinogen covered in this report include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical and Octapharma, etc.
The global Human Fibrinogen market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma
Global Human Fibrinogen market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Fibrinogen market, Segment by Type:
Human Fibrinogen Concentrate
Animal Fibrinogen Concentrate
Global Human Fibrinogen market, by Application
Congenital Fibrinogen Deficiency
Surgical Procedures
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Fibrinogen manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Fibrinogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Human Fibrinogen Market Overview
1.1 Human Fibrinogen Product Overview
1.2 Human Fibrinogen Market Segment by Type
1.2.1 Human Fibrinogen Concentrate
1.2.2 Animal Fibrinogen Concentrate
1.3 Global Human Fibrinogen Market Size by Type
1.3.1 Global Human Fibrinogen Market Size Overview by Type (2018-2029)
1.3.2 Global Human Fibrinogen Historic Market Size Review by Type (2018-2023)
1.3.3 Global Human Fibrinogen Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Fibrinogen Sales Breakdown by Type (2018-2023)
1.4.2 Europe Human Fibrinogen Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Human Fibrinogen Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Human Fibrinogen Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Human Fibrinogen Sales Breakdown by Type (2018-2023)
2 Global Human Fibrinogen Market Competition by Company
2.1 Global Top Players by Human Fibrinogen Sales (2018-2023)
2.2 Global Top Players by Human Fibrinogen Revenue (2018-2023)
2.3 Global Top Players by Human Fibrinogen Price (2018-2023)
2.4 Global Top Manufacturers Human Fibrinogen Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Fibrinogen Market Competitive Situation and Trends
2.5.1 Human Fibrinogen Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Fibrinogen Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Fibrinogen as of 2022)
2.7 Date of Key Manufacturers Enter into Human Fibrinogen Market
2.8 Key Manufacturers Human Fibrinogen Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Fibrinogen Status and Outlook by Region
3.1 Global Human Fibrinogen Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Fibrinogen Historic Market Size by Region
3.2.1 Global Human Fibrinogen Sales in Volume by Region (2018-2023)
3.2.2 Global Human Fibrinogen Sales in Value by Region (2018-2023)
3.2.3 Global Human Fibrinogen Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Human Fibrinogen Forecasted Market Size by Region
3.3.1 Global Human Fibrinogen Sales in Volume by Region (2024-2029)
3.3.2 Global Human Fibrinogen Sales in Value by Region (2024-2029)
3.3.3 Global Human Fibrinogen Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Fibrinogen by Application
4.1 Human Fibrinogen Market Segment by Application
4.1.1 Congenital Fibrinogen Deficiency
4.1.2 Surgical Procedures
4.2 Global Human Fibrinogen Market Size by Application
4.2.1 Global Human Fibrinogen Market Size Overview by Application (2018-2029)
4.2.2 Global Human Fibrinogen Historic Market Size Review by Application (2018-2023)
4.2.3 Global Human Fibrinogen Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Fibrinogen Sales Breakdown by Application (2018-2023)
4.3.2 Europe Human Fibrinogen Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Human Fibrinogen Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Human Fibrinogen Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Human Fibrinogen Sales Breakdown by Application (2018-2023)
5 North America Human Fibrinogen by Country
5.1 North America Human Fibrinogen Historic Market Size by Country
5.1.1 North America Human Fibrinogen Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Fibrinogen Sales in Volume by Country (2018-2023)
5.1.3 North America Human Fibrinogen Sales in Value by Country (2018-2023)
5.2 North America Human Fibrinogen Forecasted Market Size by Country
5.2.1 North America Human Fibrinogen Sales in Volume by Country (2024-2029)
5.2.2 North America Human Fibrinogen Sales in Value by Country (2024-2029)
6 Europe Human Fibrinogen by Country
6.1 Europe Human Fibrinogen Historic Market Size by Country
6.1.1 Europe Human Fibrinogen Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Fibrinogen Sales in Volume by Country (2018-2023)
6.1.3 Europe Human Fibrinogen Sales in Value by Country (2018-2023)
6.2 Europe Human Fibrinogen Forecasted Market Size by Country
6.2.1 Europe Human Fibrinogen Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Fibrinogen Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Fibrinogen by Region
7.1 Asia-Pacific Human Fibrinogen Historic Market Size by Region
7.1.1 Asia-Pacific Human Fibrinogen Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Fibrinogen Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Human Fibrinogen Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Human Fibrinogen Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Fibrinogen Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Fibrinogen Sales in Value by Region (2024-2029)
8 Latin America Human Fibrinogen by Country
8.1 Latin America Human Fibrinogen Historic Market Size by Country
8.1.1 Latin America Human Fibrinogen Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Fibrinogen Sales in Volume by Country (2018-2023)
8.1.3 Latin America Human Fibrinogen Sales in Value by Country (2018-2023)
8.2 Latin America Human Fibrinogen Forecasted Market Size by Country
8.2.1 Latin America Human Fibrinogen Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Fibrinogen Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Fibrinogen by Country
9.1 Middle East and Africa Human Fibrinogen Historic Market Size by Country
9.1.1 Middle East and Africa Human Fibrinogen Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Fibrinogen Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Human Fibrinogen Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Human Fibrinogen Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Fibrinogen Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Fibrinogen Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CSL Behring
10.1.1 CSL Behring Company Information
10.1.2 CSL Behring Introduction and Business Overview
10.1.3 CSL Behring Human Fibrinogen Sales, Revenue and Gross Margin (2018-2023)
10.1.4 CSL Behring Human Fibrinogen Products Offered
10.1.5 CSL Behring Recent Development
10.2 LFB Group
10.2.1 LFB Group Company Information
10.2.2 LFB Group Introduction and Business Overview
10.2.3 LFB Group Human Fibrinogen Sales, Revenue and Gross Margin (2018-2023)
10.2.4 LFB Group Human Fibrinogen Products Offered
10.2.5 LFB Group Recent Development
10.3 Shanghai RAAS Blood Products
10.3.1 Shanghai RAAS Blood Products Company Information
10.3.2 Shanghai RAAS Blood Products Introduction and Business Overview
10.3.3 Shanghai RAAS Blood Products Human Fibrinogen Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Shanghai RAAS Blood Products Human Fibrinogen Products Offered
10.3.5 Shanghai RAAS Blood Products Recent Development
10.4 Jiangxi Boya Bio-Pharmaceutical
10.4.1 Jiangxi Boya Bio-Pharmaceutical Company Information
10.4.2 Jiangxi Boya Bio-Pharmaceutical Introduction and Business Overview
10.4.3 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Products Offered
10.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Development
10.5 Hualan Biological Engineering
10.5.1 Hualan Biological Engineering Company Information
10.5.2 Hualan Biological Engineering Introduction and Business Overview
10.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hualan Biological Engineering Human Fibrinogen Products Offered
10.5.5 Hualan Biological Engineering Recent Development
10.6 Harbin Pacific Biopharmaceutical
10.6.1 Harbin Pacific Biopharmaceutical Company Information
10.6.2 Harbin Pacific Biopharmaceutical Introduction and Business Overview
10.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Products Offered
10.6.5 Harbin Pacific Biopharmaceutical Recent Development
10.7 GREEN CROSS
10.7.1 GREEN CROSS Company Information
10.7.2 GREEN CROSS Introduction and Business Overview
10.7.3 GREEN CROSS Human Fibrinogen Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GREEN CROSS Human Fibrinogen Products Offered
10.7.5 GREEN CROSS Recent Development
10.8 Shanghai XinXing Medical
10.8.1 Shanghai XinXing Medical Company Information
10.8.2 Shanghai XinXing Medical Introduction and Business Overview
10.8.3 Shanghai XinXing Medical Human Fibrinogen Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Shanghai XinXing Medical Human Fibrinogen Products Offered
10.8.5 Shanghai XinXing Medical Recent Development
10.9 Octapharma
10.9.1 Octapharma Company Information
10.9.2 Octapharma Introduction and Business Overview
10.9.3 Octapharma Human Fibrinogen Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Octapharma Human Fibrinogen Products Offered
10.9.5 Octapharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Fibrinogen Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Fibrinogen Industrial Chain Analysis
11.4 Human Fibrinogen Market Dynamics
11.4.1 Human Fibrinogen Industry Trends
11.4.2 Human Fibrinogen Market Drivers
11.4.3 Human Fibrinogen Market Challenges
11.4.4 Human Fibrinogen Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Fibrinogen Distributors
12.3 Human Fibrinogen Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
